Literature DB >> 23473674

Escherichia coli ST131: variations on a theme of clonal expansion.

Ritu Banerjee, James R Johnson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23473674      PMCID： PMC3916147          DOI： 10.1016/j.eimc.2013.01.004

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN： 0213-005X            Impact factor:   1.731


× No keyword cloud information.
  19 in total

Review 1.  CTX-M: changing the face of ESBLs in Europe.

Authors:  David M Livermore; Rafael Canton; Marek Gniadkowski; Patrice Nordmann; Gian Maria Rossolini; Guillaume Arlet; Juan Ayala; Teresa M Coque; Izabela Kern-Zdanowicz; Francesco Luzzaro; Laurent Poirel; Neil Woodford
Journal:  J Antimicrob Chemother       Date:  2006-12-06       Impact factor: 5.790

2.  Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States.

Authors:  James R Johnson; Brian Johnston; Connie Clabots; Michael A Kuskowski; Mariana Castanheira
Journal:  Clin Infect Dis       Date:  2010-08-01       Impact factor: 9.079

3.  National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain.

Authors:  Jorge Blanco; Azucena Mora; Rosalia Mamani; Cecilia López; Miguel Blanco; Ghizlane Dahbi; Alexandra Herrera; Jesús E Blanco; María Pilar Alonso; Fernando García-Garrote; Fernando Chaves; María Ángeles Orellana; Luis Martínez-Martínez; Jorge Calvo; Guillem Prats; María Nieves Larrosa; Juan José González-López; Lorena López-Cerero; Jesús Rodríguez-Baño; Alvaro Pascual
Journal:  J Antimicrob Chemother       Date:  2011-06-13       Impact factor: 5.790

4.  Commonality among fluoroquinolone-resistant sequence type ST131 extraintestinal Escherichia coli isolates from humans and companion animals in Australia.

Authors:  Joanne L Platell; Rowland N Cobbold; James R Johnson; Anke Heisig; Peter Heisig; Connie Clabots; Michael A Kuskowski; Darren J Trott
Journal:  Antimicrob Agents Chemother       Date:  2011-06-06       Impact factor: 5.191

Review 5.  Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain.

Authors:  Benjamin A Rogers; Hanna E Sidjabat; David L Paterson
Journal:  J Antimicrob Chemother       Date:  2010-11-16       Impact factor: 5.790

6.  Clinical and molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli causing bacteremia in the Rotterdam Area, Netherlands.

Authors:  Akke K van der Bij; Gisele Peirano; Wil H F Goessens; Eric R van der Vorm; M van Westreenen; Johann D D Pitout
Journal:  Antimicrob Agents Chemother       Date:  2011-04-18       Impact factor: 5.191

7.  Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15.

Authors:  Marie-Hélène Nicolas-Chanoine; Jorge Blanco; Véronique Leflon-Guibout; Raphael Demarty; Maria Pilar Alonso; Maria Manuela Caniça; Yeon-Joon Park; Jean-Philippe Lavigne; Johann Pitout; James R Johnson
Journal:  J Antimicrob Chemother       Date:  2007-12-11       Impact factor: 5.790

8.  Molecular characteristics of travel-related extended-spectrum-beta-lactamase-producing Escherichia coli isolates from the Calgary Health Region.

Authors:  Johann D D Pitout; Lorraine Campbell; Deirdre L Church; Daniel B Gregson; Kevin B Laupland
Journal:  Antimicrob Agents Chemother       Date:  2009-04-13       Impact factor: 5.191

9.  Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15.

Authors:  Teresa M Coque; Angela Novais; Alessandra Carattoli; Laurent Poirel; Johann Pitout; Luísa Peixe; Fernando Baquero; Rafael Cantón; Patrice Nordmann
Journal:  Emerg Infect Dis       Date:  2008-02       Impact factor: 6.883

10.  Food reservoir for Escherichia coli causing urinary tract infections.

Authors:  Caroline Vincent; Patrick Boerlin; Danielle Daignault; Charles M Dozois; Lucie Dutil; Chrissi Galanakis; Richard J Reid-Smith; Pierre Paul Tellier; Patricia A Tellis; Kim Ziebell; Amee R Manges
Journal:  Emerg Infect Dis       Date:  2010-01       Impact factor: 6.883
View more
  5 in total

1.  Genomic and Functional Portrait of a Highly Virulent, CTX-M-15-Producing H30-Rx Subclone of Escherichia coli Sequence Type 131.

Authors:  Amit Ranjan; Sabiha Shaik; Arif Hussain; Nishant Nandanwar; Torsten Semmler; Savita Jadhav; Lothar H Wieler; Niyaz Ahmed
Journal:  Antimicrob Agents Chemother       Date:  2015-07-20       Impact factor: 5.191

2.  Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli in Riyadh: emergence of CTX-M-15-producing E. coli ST131.

Authors:  Mohamed H Al-Agamy; Atef M Shibl; Mohamed M Hafez; Mohammad N Al-Ahdal; Ziad A Memish; Harish Khubnani
Journal:  Ann Clin Microbiol Antimicrob       Date:  2014-01-07       Impact factor: 3.944

3.  Risk Factors For and Outcomes of Multidrug-Resistant Escherichia coli Infections in Children.

Authors:  Adaora S Uzodi; Christine M Lohse; Ritu Banerjee
Journal:  Infect Dis Ther       Date:  2017-04-03

Review 4.  Genomic interplay in bacterial communities: implications for growth promoting practices in animal husbandry.

Authors:  Piklu Roy Chowdhury; Jessica McKinnon; Ethan Wyrsch; Jeffrey M Hammond; Ian G Charles; Steven P Djordjevic
Journal:  Front Microbiol       Date:  2014-08-12       Impact factor: 5.640

Review 5.  Tackling Drug Resistant Infection Outbreaks of Global Pandemic Escherichia coli ST131 Using Evolutionary and Epidemiological Genomics.

Authors:  Tim Downing
Journal:  Microorganisms       Date:  2015-05-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.